{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:54:10Z","timestamp":1791647650347,"version":"4.3.4"},"reference-count":76,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,6,18]]},"DOI":"10.1001\/jama.2019.6587","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T12:10:26Z","timestamp":1560255026000},"page":"2326","source":"Crossref","is-referenced-by-count":194,"title":["Screening for HIV Infection"],"prefix":"10.1001","volume":"321","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Owens","sequence":"additional","affiliation":[{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California"},{"name":"Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina W.","family":"Davidson","sequence":"additional","affiliation":[{"name":"Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Krist","sequence":"additional","affiliation":[{"name":"Fairfax Family Practice Residency, Fairfax, Virginia"},{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cabana","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Curry","sequence":"additional","affiliation":[{"name":"University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyke A.","family":"Doubeni","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John W.","family":"Epling","sequence":"additional","affiliation":[{"name":"Virginia Tech Carilion School of Medicine, Roanoke"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kubik","sequence":"additional","affiliation":[{"name":"Temple University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Seth","family":"Landefeld","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Pbert","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Simon","sequence":"additional","affiliation":[{"name":"Northwestern University, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Tseng","sequence":"additional","affiliation":[{"name":"University of Hawaii, Honolulu"},{"name":"Pacific Health Research and Education Institute, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Tufts University, Medford, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"jus190010r3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7326\/M17-2082","article-title":"HIV incidence, prevalence, and undiagnosed infections in U.S. men who have sex with men.","volume":"168","author":"Singh","year":"2018","journal-title":"Ann Intern Med"},{"issue":"47","key":"jus190010r4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.15585\/mmwr.mm6647e1","article-title":"Vital signs: human immunodeficiency virus testing and diagnosis delays\u2014United States.","volume":"66","author":"Dailey","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"jus190010r6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/QAI.0000000000001552","article-title":"Brief report: estimated incidence of perinatally acquired HIV infection in the United States, 1978-2013.","volume":"76","author":"Nesheim","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"jus190010r7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/INF.0000000000001355","article-title":"Perinatal antiretroviral exposure and prevented mother-to-child HIV infections in the era of antiretroviral prophylaxis in the United States, 1994-2010.","volume":"36","author":"Little","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-14","key":"jus190010r10","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"31","key":"jus190010r11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.15585\/mmwr.mm6631a3","article-title":"Recommendations for HIV screening of gay, bisexual, and other men who have sex with men\u2014United States, 2017.","volume":"66","author":"DiNenno","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"jus190010r12","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1097\/AOG.0000000000002825","article-title":"ACOG Committee Opinion No. 752: prenatal and perinatal human immunodeficiency virus testing.","volume":"132","author":"Committee on Obstetric Practice","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"12","key":"jus190010r14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.7326\/M14-1965","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: U.S. PreventiveServices Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"jus190010r16","article-title":"Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement","author":"US Preventive Services Task Force","journal-title":"JAMA"},{"key":"jus190010r23","article-title":"Screening for HIV infection in asymptomatic, nonpregnant adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force","author":"Chou","journal-title":"JAMA"},{"key":"jus190010r25","article-title":"Screening for HIV infection in pregnant women: updated evidence report and systematic review for the US Preventive Services Task Force","author":"Selph","journal-title":"JAMA"},{"issue":"6","key":"jus190010r27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"jus190010r28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.","volume":"14","author":"Grinsztejn","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"jus190010r29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection.","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"jus190010r30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa.","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"jus190010r31","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2352-3018(15)00108-3","article-title":"Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.","volume":"2","author":"Lodi","year":"2015","journal-title":"Lancet HIV"},{"issue":"14","key":"jus190010r32","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/QAD.0000000000000790","article-title":"Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes","volume":"29","author":"Lima","year":"2015","journal-title":"AIDS"},{"issue":"7","key":"jus190010r33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/cid\/civ463","article-title":"Age at entry into care, timing of antiretroviral therapy initiation, and 10-year mortality among HIV-seropositive adults in the United States.","volume":"61","author":"Edwards","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9","key":"jus190010r34","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission.","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"jus190010r35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"jus190010r36","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study","author":"Rodger","journal-title":"Lancet"},{"issue":"8","key":"jus190010r37","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3018(18)30132-2","article-title":"Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.","volume":"5","author":"Bavinton","year":"2018","journal-title":"Lancet HIV"},{"issue":"8","key":"jus190010r38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6708a1","article-title":"Youth risk behavior surveillance\u2014United States, 2017.","volume":"67","author":"Kann","year":"2018","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"jus190010r39","first-page":"1","article-title":"Youth risk behavior surveillance\u2014United States, 2011.","volume":"61","author":"Eaton","year":"2012","journal-title":"MMWR Surveill Summ"},{"issue":"2","key":"jus190010r40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/QAI.0000000000001350","article-title":"Brief report: randomized, double-blind comparison of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E\/C\/F) for initial HIV-1 treatment: week 144 results.","volume":"75","author":"Arribas","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"jus190010r41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/QAI.0b013e31828ace69","article-title":"Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir\/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.","volume":"63","author":"Rockstroh","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"jus190010r42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/QAI.0b013e31826f993c","article-title":"No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis.","volume":"61","author":"Ding","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"jus190010r43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-016-0588-4","article-title":"Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? a cohort collaboration.","volume":"14","author":"Sabin","year":"2016","journal-title":"BMC Med"},{"issue":"3","key":"jus190010r44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/cid\/civ316","article-title":"Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population.","volume":"61","author":"Desai","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"jus190010r45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M14-0293","article-title":"Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.","volume":"161","author":"Mollan","year":"2014","journal-title":"Ann Intern Med"},{"issue":"4","key":"jus190010r46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/QAI.0000000000000606","article-title":"Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral therapy: a systematic review and meta-analysis of randomized trials.","volume":"69","author":"Ford","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"jus190010r47","doi-asserted-by":"publisher","first-page":"19512","DOI":"10.7448\/IAS.17.4.19512","article-title":"Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study.","volume":"17","author":"Smith","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"jus190010r48","doi-asserted-by":"publisher","first-page":"e2480","DOI":"10.1097\/MD.0000000000002480","article-title":"No evidence of an association between efavirenz exposure and suicidality among HIV patients initiating antiretroviral therapy in a retrospective cohort study of real world data.","volume":"95","author":"Nkhoma","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"jus190010r49","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/QAD.0000000000001018","article-title":"Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.","volume":"30","author":"Ryom","year":"2016","journal-title":"AIDS"},{"issue":"6","key":"jus190010r50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cid\/cis919","article-title":"Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the Data Collection on Adverse Events of Anti-HIV Drugs study.","volume":"56","author":"Kovari","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"jus190010r51","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/infdis\/jit043","article-title":"Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.","volume":"207","author":"Ryom","year":"2013","journal-title":"J Infect Dis"},{"issue":"7","key":"jus190010r52","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection.","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"issue":"4","key":"jus190010r53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/cid\/cis937","article-title":"Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up.","volume":"56","author":"Laprise","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"10","key":"jus190010r54","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cix167","article-title":"Antiretrovirals, fractures, and osteonecrosis in a large international HIV cohort.","volume":"64","author":"Borges","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"18","key":"jus190010r55","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention.","volume":"375","author":"Fowler","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"jus190010r56","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.","volume":"206","author":"Chen","year":"2012","journal-title":"J Infect Dis"},{"issue":"4","key":"jus190010r57","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/hiv.12083","article-title":"Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.","volume":"15","author":"Short","year":"2014","journal-title":"HIV Med"},{"issue":"10","key":"jus190010r58","doi-asserted-by":"publisher","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy.","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"jus190010r59","doi-asserted-by":"publisher","first-page":"19933","DOI":"10.7448\/IAS.18.1.19933","article-title":"Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?","volume":"18","author":"Kakkar","year":"2015","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"jus190010r60","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.12680","article-title":"Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.","volume":"121","author":"Kreitchmann","year":"2014","journal-title":"BJOG"},{"issue":"9","key":"jus190010r61","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/cid\/cis198","article-title":"Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?","volume":"54","author":"Sibiude","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"jus190010r62","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/infdis\/jis728","article-title":"Combination antiretroviral use and preterm birth.","volume":"207","author":"Watts","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"jus190010r63","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/INF.0000000000000410","article-title":"Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.","volume":"33","author":"Nozyce","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"jus190010r64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAD.0000000000000916","article-title":"Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.","volume":"30","author":"Williams","year":"2016","journal-title":"AIDS"},{"issue":"2","key":"jus190010r65","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ajog.2003.07.018","article-title":"Maternal toxicity and pregnancy complications in human immunodeficiency virus\u2013infected women receiving antiretroviral therapy: PACTG 316.","volume":"190","author":"Watts","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"jus190010r66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.","volume":"38","author":"Tuomala","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"jus190010r67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/00016340601148531","article-title":"Obstetric and perinatal complications in HIV-infected women: analysis of a cohort of 167 pregnancies between 1997 and 2003.","volume":"86","author":"Mart\u00ed","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"jus190010r68","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/1471-2334-13-522","article-title":"Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.","volume":"13","author":"Sartorius","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"jus190010r69","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/0003-4819-159-1-201307020-00645","article-title":"Screening for HIV: U.S. Preventive Services Task Force recommendation statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"jus190010r70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/0003-4819-150-2-200901200-00300","article-title":"Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association.","volume":"150","author":"Qaseem","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"jus190010r71","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1086\/599326","article-title":"HIV policy: the path forward\u2014a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians.","volume":"48","author":"Lubinski","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"jus190010r72","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/01.AOG.0000446828.64137.50","article-title":"ACOG Committee Opinion No 596: routine human immunodeficiency virus screening.","volume":"123","author":"Committee on Gynecologic Practice","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"jus190010r73","doi-asserted-by":"publisher","first-page":"e20170254","DOI":"10.1542\/peds.2017-0254","article-title":"2017 Recommendations for preventive pediatric health care.","volume":"139","author":"Committee on Practice and Ambulatory Medicine","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"jus190010r75","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1542\/peds.2008-2175","article-title":"HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.","volume":"122","author":"American Academy of Pediatrics Committee on Pediatric AIDS","year":"2008","journal-title":"Pediatrics"},{"key":"jus190010r76","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1542\/peds.2011-1808","article-title":"AAP publications reaffirmed and retired.","volume":"128","author":"American Academy of Pediatrics","year":"2011","journal-title":"Pediatrics"},{"key":"jus190010r22","volume-title":"Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: A Systematic Review for the US Preventive Services Task Force: Evidence Synthesis No. 176","author":"Chou","year":"2019"},{"key":"jus190010r24","volume-title":"Screening for HIV Infection in Pregnant Women: A Systematic Review for the US Preventive Services Task Force: Evidence Synthesis No. 177","author":"Selph","year":"2019"},{"key":"jus190010r1","unstructured":"Centers for Disease Control and Prevention (CDC). Estimated HIV Incidence and Prevalence in the United States, 2010\u20132016. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-supplemental-report-vol-24-1.pdf. Published February 2019. Accessed April 9, 2019."},{"key":"jus190010r2","unstructured":"Centers for Disease Control and Prevention (CDC). Diagnoses of HIV Infection in the United States and Dependent Areas, 2017. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2017-vol-29.pdf. Published November 2018. Accessed April 5, 2019."},{"key":"jus190010r5","unstructured":"Panel on Treatment of Pregnant Women With HIV Infection and Prevention of Perinatal Transmission, US Department of Health and Human Services. Recommendations for the Use of Antiretroviral Drugs in Pregnant Women With HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. AIDSinfo website. https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf. Accessed April 5, 2019."},{"key":"jus190010r8","unstructured":"Centers for Disease Control and Prevention (CDC). Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. CDC website. https:\/\/stacks.cdc.gov\/view\/cdc\/23447. Published June 2014. Accessed April 5, 2019."},{"key":"jus190010r9","unstructured":"Centers for Disease Control and Prevention (CDC). 2018 Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens. CDC website. https:\/\/stacks.cdc.gov\/view\/cdc\/50872. Updated January 2018. Accessed April 5, 2019."},{"key":"jus190010r13","unstructured":"US Department of Health and Human Services. Clinical guidelines. AIDSinfo website. https:\/\/aidsinfo.nih.gov\/guidelines\/. Updated 2019. Accessed April 5, 2019."},{"key":"jus190010r15","unstructured":"HIV\/AIDS, STIs and pregnancy. The Community Guide website. https:\/\/www.thecommunityguide.org\/topic\/hivaids-stis-and-pregnancy. Accessed April 5, 2019."},{"key":"jus190010r17","unstructured":"HIV.gov website. https:\/\/www.hiv.gov\/. Accessed April 5, 2019."},{"key":"jus190010r18","unstructured":"Centers for Disease Control and Prevention (CDC). HIV\/AIDS. CDC website. https:\/\/www.cdc.gov\/hiv\/. Updated 2019. Accessed April 5, 2019."},{"key":"jus190010r19","unstructured":"Centers for Disease Control and Prevention (CDC). Recommendations for HIV Prevention With Adults and Adolescents With HIV in the United States, 2014: Summary for Clinical Providers. CDC website. https:\/\/stacks.cdc.gov\/view\/cdc\/44065. Updated December 2016. Accessed April 5, 2019."},{"key":"jus190010r20","unstructured":"Centers for Disease Control and Prevention (CDC). 2015 Sexually Transmitted Diseases Treatment Guidelines: HIV infection: detection, counseling, and referral. CDC website. https:\/\/www.cdc.gov\/std\/tg2015\/hiv.htm. June 2015. Accessed April 5, 2019."},{"key":"jus190010r21","unstructured":"Centers for Disease Control and Prevention (CDC). HIV and pregnant women, infants, and children. CDC website. https:\/\/www.cdc.gov\/hiv\/group\/gender\/pregnantwomen\/index.html. Updated March 29, 2019. Accessed April 5, 2019."},{"key":"jus190010r26","unstructured":"Centers for Disease Control and Prevention (CDC). Rapid HIV tests suitable for use in clinical settings (CLIA-moderate complexity). https:\/\/www.cdc.gov\/hiv\/pdf\/testing\/rapid-hiv-tests-clinical-moderate-complexity.pdf. Updated August 2016. Accessed April 5, 2019."},{"key":"jus190010r74","unstructured":"American Academy of Family Physicians (AAFP). Clinical Preventive Service Recommendation: HIV Screening, Adolescents and Adults. AAFP website. https:\/\/www.aafp.org\/patient-care\/clinical-recommendations\/all\/hiv-screening.html. Published 2013. Accessed April 5, 2019."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/23\/2326\/17668755\/jama_owens_2019_us_190010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T07:19:21Z","timestamp":1663658361000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.6587"}},"subtitle":["US Preventive Services Task Force Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":76,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,6,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.6587","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,18]]}}}